We look for

Good people

with

Great ideas

who are

Well organized…

Investments we Seek

Our Family office makes a lot of investments, but there are a few areas that we are most excited about…

  • We love discovering new innovations and empowering entrepreneurs to unlock their visions of our collective future. We work closely with angel groups and accelerators to maximize our exposure to these front-line creators and help where we can.

  • Companies with solid traction who are seeking capital to unlock rapid growth.

  • Succession doesn’t come easy.

    The right buyer is the one who shares your excitement for all that your company is and can become. That is what we strive to be.

 Our Core Criteria

  • Great people, with complementary skillsets, who are committed to the cause makes all the difference. Strong and diverse teams unlock performance by making better decisions while avoiding their blindspots.

  • Companies that have demonstrated some degree of product market fit.

  • Businesses that are either protected by IP, have discernible and novel offerings, or have a loyal customer base because they can defend their revenues and margins.

  • Most entrepreneurs set out to change the world. The best entrepreneurs are the ones who can navigate the daily needs of the business and steadily nudge it towards their ultimate goal. We look for teams that have clarity, focus, and vision and avoid chasing every opportunity that comes knocking.

    Can you explain what your business does and its vision in a single sentence? Most can’t.

  • We invest in businesses with strong unit economics and who’s management team intimately understands their key factors.

  • While we are industry agnostic, we do focus more on SaaS, DeepTech, Manufacturing, PropTech, and CleanTech.

Think your company is a fit for Blue River?

If so, please reach out!

Some of our recent highlights

Altitude Accelerator

April 2024

Blue River became an official Venture Capital Partner

Learn more

Arma Biosciences

April 2024

At-home health monitoring platform targeting clinically proven biomarkers.

Panaxium

March 2024

Brain-machine interface aimed at improving stroke patient recovery.

Founded

Blue River Capital

December 2023

Axe Buildings

August 2024

Modular home builder tackling the housing affordability crisis